Stress-motivated Alcohol Use as a Value-based Decision-making Process
Launched by UNIVERSITY OF WASHINGTON · Feb 15, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how stress affects people's decisions to drink alcohol. Researchers want to find out if feeling stressed makes regular drinkers want to consume more alcohol and how that decision-making process works. Participants will be placed in one of four groups: some will experience stress and have the option to drink alcohol, others will experience stress but not be allowed to drink, some will not feel stressed and can drink, and the last group will neither feel stressed nor drink. Everyone will take part in a decision-making task twice—once before and once after these experiences.
To join the study, you should be someone who drinks alcohol at least once a week and usually consumes a certain amount (four drinks for women and five for men) on occasion. However, you cannot participate if you are pregnant, have certain anxiety disorders, are currently being treated for alcohol use, or have medical conditions that make drinking unsafe. If you decide to take part, you’ll help researchers better understand the link between stress and alcohol consumption, which could lead to improved support for individuals facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Drinking alcohol at least once a week
- • Consuming 4 (female) or 5 (male) drinks in one occasion at least once a month
- Exclusion Criteria:
- • Currently pregnant or trying to become pregnant
- • Past or current diagnosis of an anxiety disorder, such as Generalized Anxiety Disorder or Post-Traumatic Stress Disorder
- • Past or current treatment for alcohol use
- • Past or current medical condition that contraindicates alcohol use
- • Past or current reaction to alcohol that contraindicates alcohol use
- • Past or current medication that contraindicates alcohol use
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Kevin M King, PhD
Study Director
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported